News|Articles|May 13, 2024
Pfizer CentreOne Perspectives: Sterile Injectable Capabilities and Responding to Emerging Trends
Author(s)Pfizer CentreOne
Sterile injectables (SI) and complex biologics can be leveraged from both a technical and business development standpoint. Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
Challenges for the Global Manufacturing of Vaccines
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
